Recent evidence suggests that the severity of COVID-19 was related to microbiome changes, as SARS-CoV-2 replicates in cells expressing angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serines 2 receptors, both of which are found in the oral and nasal mucosa (4). This evidence concerns the gene ACE2 and COVID-19.